Peter Münzel

1.5k total citations
38 papers, 1.3k citations indexed

About

Peter Münzel is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Peter Münzel has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 13 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Peter Münzel's work include Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (11 papers) and Carcinogens and Genotoxicity Assessment (7 papers). Peter Münzel is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (11 papers) and Carcinogens and Genotoxicity Assessment (7 papers). Peter Münzel collaborates with scholars based in Germany, France and Sweden. Peter Münzel's co-authors include Karl Walter Bock, Barbara S. Bock-Hennig, Harald Gschaidmeier, Klaus Koschel, Gerhard Bookjans, Christoph Köhle, Brian Burchell, Dieter Schrenk, Albert Braeuning and Sylvie Fournel‐Gigleux and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Peter Münzel

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Münzel Germany 22 553 507 397 232 211 38 1.3k
I S Owens United States 12 524 0.9× 746 1.5× 235 0.6× 206 0.9× 596 2.8× 17 1.4k
Nghia Nguyen United States 19 436 0.8× 589 1.2× 382 1.0× 144 0.6× 409 1.9× 31 1.4k
Alison E.M. Vickers United States 23 503 0.9× 443 0.9× 330 0.8× 126 0.5× 138 0.7× 55 1.5k
David R. Plowchalk United States 20 330 0.6× 270 0.5× 264 0.7× 149 0.6× 130 0.6× 27 1.4k
T.C. Orton United Kingdom 16 292 0.5× 633 1.2× 274 0.7× 271 1.2× 83 0.4× 40 1.4k
Fay K. Kessler United States 16 433 0.8× 457 0.9× 301 0.8× 74 0.3× 257 1.2× 26 1.1k
Hans Postlind Sweden 13 805 1.5× 393 0.8× 457 1.2× 83 0.4× 96 0.5× 19 1.4k
Jean-Pierre Flinois France 21 805 1.5× 405 0.8× 433 1.1× 96 0.4× 109 0.5× 31 1.4k
Georg F. Kahl Germany 16 211 0.4× 269 0.5× 373 0.9× 153 0.7× 91 0.4× 34 820
Iain G. C. Robertson New Zealand 21 262 0.5× 568 1.1× 153 0.4× 272 1.2× 88 0.4× 49 1.1k

Countries citing papers authored by Peter Münzel

Since Specialization
Citations

This map shows the geographic impact of Peter Münzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Münzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Münzel more than expected).

Fields of papers citing papers by Peter Münzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Münzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Münzel. The network helps show where Peter Münzel may publish in the future.

Co-authorship network of co-authors of Peter Münzel

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Münzel. A scholar is included among the top collaborators of Peter Münzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Münzel. Peter Münzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lankisch, Tim O., Thomas Erichsen, Ursula Ehmer, et al.. (2008). Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene. Archives of Toxicology. 82(9). 573–582. 33 indexed citations
2.
Erichsen, Thomas, Ursula Ehmer, Sandra Kalthoff, et al.. (2008). Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene. Toxicology and Applied Pharmacology. 230(2). 252–260. 48 indexed citations
3.
Köhle, Christoph, et al.. (2006). REGULATION OF CYP1A1 GENE EXPRESSION BY THE ANTIOXIDANT TERT-BUTYLHYDROQUINONE. Drug Metabolism and Disposition. 34(7). 1096–1101. 19 indexed citations
4.
Bock, Karl Walter, et al.. (1999). FUNCTIONS AND TRANSCRIPTIONAL REGULATION OF PAH-INDUCIBLE HUMAN UDP-GLUCURONOSYL-TRANSFERASES. Drug Metabolism Reviews. 31(2). 411–422. 49 indexed citations
5.
Bock, Karl Walter, et al.. (1998). Ah receptor-controlled transcriptional regulation and function of rat and human UDP-glucuronosyltransferase isoforms. Advances in Enzyme Regulation. 38(1). 207–222. 35 indexed citations
6.
Münzel, Peter, et al.. (1998). Aryl Hydrocarbon Receptor-Inducible or Constitutive Expression of Human UDP Glucuronosyltransferase UGT1A6. Archives of Biochemistry and Biophysics. 350(1). 72–78. 50 indexed citations
8.
Münzel, Peter, et al.. (1996). Tissue-Specific 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Inducible Expression of Human UDP-Glucuronosyltransferase UGT1A6. Archives of Biochemistry and Biophysics. 335(1). 205–210. 56 indexed citations
9.
Münzel, Peter, et al.. (1996). Growth modulation of hepatocytes and rat liver epithelial cells (WB-F344) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Carcinogenesis. 17(2). 197–202. 24 indexed citations
10.
Münzel, Peter, et al.. (1994). Tissue-specific constitutive and inducible expression of rat phenol UDP-glucuronosyltransferase. Biochemical Pharmacology. 47(8). 1445–1448. 44 indexed citations
11.
Steinberg, Pablo, R. Steinbrecher, Dieter Schrenk, et al.. (1994). Drug-metabolizing enzyme activities in freshly isolated oval cells and in an established oval cell line from carcinogen-fed rats. Cell Biology and Toxicology. 10(1). 59–65. 5 indexed citations
12.
Münzel, Peter, Annie Pfohl‐Leszkowicz, Elke Röhrdanz, et al.. (1991). Site-specific hypomethylation of c-myc protooncogene in liver nodules and inhibition of DNA methylation by N-nitrosomorpholine. Biochemical Pharmacology. 42(2). 365–371. 12 indexed citations
13.
Schrenk, Dieter, et al.. (1991). Immunochemical localization and functional characterization of cytochrome P450IIE1 in rat hepatocyte foci and nodules. Carcinogenesis. 12(12). 2353–2356. 4 indexed citations
14.
Münzel, Peter, et al.. (1991). Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas. Journal of Cancer Research and Clinical Oncology. 117(6). 603–607. 33 indexed citations
15.
16.
Zeidler, H. & Peter Münzel. (1989). NSAIDs: New Approaches to Limiting Gastropathy. Scandinavian Journal of Rheumatology. 18(sup78). 18–23. 3 indexed citations
17.
Münzel, Peter & K.W. Bock. (1989). Hypomethylation of c-myc Proto-oncogene of N-Nitrosomorpholine — Induced Rat Liver Nodules and of H4IIE Cells. Archives of toxicology. Supplement. 13. 211–213. 6 indexed citations
18.
Wölfle, Detlef, et al.. (1988). Altered growth control of rat hepatocytes after treatment with 3,4,3′,4′-tetrachlorobiphenylin vivo and in vitro. Carcinogenesis. 9(6). 919–924. 24 indexed citations
19.
Koschel, Klaus & Peter Münzel. (1984). Inhibition of opiate receptor-mediated signal transmission by rabies virus in persistently infected NG-108-15 mouse neuroblastoma-rat glioma hybrid cells.. Proceedings of the National Academy of Sciences. 81(3). 950–954. 20 indexed citations
20.
Münzel, Peter, Dennis P. Healy, & Paul A. Insel. (1984). Autoradiographic localization of beta-adrenergic receptors in rat kidney slices using [125I]iodocyanopindolol. American Journal of Physiology-Renal Physiology. 246(2). F240–F245. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026